You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Angiotensinogen

Showing 1 - 25 of 146
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes, Hypertension Trial in New Orleans (Dapagliflozin, Sulfonylurea, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Hypertension
  • New Orleans, Louisiana
    Tulane University
Oct 5, 2022

Chronic Heart Failure With Reduced Ejection Fraction Trial in Hungary, Poland, United States (IONIS-AGT-LRx, Placebo)

Active, not recruiting
  • Chronic Heart Failure With Reduced Ejection Fraction
  • Little Rock, Arkansas
  • +25 more
Jul 27, 2022

Hypertension Trial in Canada, United States (IONIS-AGT-LRx, Placebo)

Active, not recruiting
  • Hypertension
  • Anniston, Alabama
  • +49 more
Aug 6, 2022

Hypertension Trial in United States (IONIS-AGT-LRx, Placebo)

Completed
Has Results
  • Hypertension
  • Placebo
  • ISIS 757456
  • Birmingham, Alabama
  • +8 more
Dec 21, 2022

Hypertension Trial in United States (ION904, Placebo)

Recruiting
  • Hypertension
  • Cypress, California
  • +7 more
Aug 4, 2022

Diabetes Trial in Boston (Para-aminohippuric Acid, Angiotensin II, Norepinephrine)

Terminated
  • Diabetes Mellitus
  • Para-aminohippuric Acid
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital- 221 Longwood Avenue
Nov 7, 2022

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

Salt; Excess, Blood Pressure Disorders Trial in Winston-Salem (Allopurinol, Dietary Intervention)

Recruiting
  • Salt; Excess
  • Blood Pressure Disorders
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 20, 2022

Septic Shock, Shock, Sepsis Trial (Angiotensin II and hydrocortisone sodium succinate)

Not yet recruiting
  • Septic Shock
  • +3 more
  • Angiotensin II and hydrocortisone sodium succinate
  • (no location specified)
Nov 3, 2023

ICU Treated COVID-19: Risk Factors for 1-year Mortality

Completed
  • Covid19
  • No intervention.
  • Uppsala, Sweden
    Uppsala University
May 17, 2022

Septic Shock, Acute Kidney Injury Trial in Lexington (Standard of Care, Angiotensin II)

Recruiting
  • Septic Shock
  • Acute Kidney Injury
  • Standard of Care
  • Angiotensin II
  • Lexington, Kentucky
    University of Kentucky HealthCare Chandler Medical Center
Dec 7, 2022

RAAS-axis in Patients Undergoing Cardiac Surgery

Not yet recruiting
  • Vasoplegia
  • Vasoplegic Shock
  • on-pump surgery
  • off-pump surgery
  • Münster, Germany
    University Hospital Münster; Department of Anesthesiology, Inten
Apr 25, 2023

Hypertension Trial in Edinburgh, London, Manchester (ALN-AGT01, ALN-AGT01-Matching Placebo, Irbesartan)

Completed
  • Hypertension
  • Edinburgh, United Kingdom
  • +2 more
Jan 13, 2023

Chronic Kidney Diseases, Cardiovascular Diseases, Hypertension Trial (Fruits and vegetables (F+V), NaHCO3 Tablets, Usual Care)

Completed
  • Chronic Kidney Diseases
  • +2 more
  • Fruits and vegetables (F+V)
  • +2 more
  • (no location specified)
Sep 18, 2023

Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury Trial in Los Angeles (Angiotensin II, Norepinephrine)

Enrolling by invitation
  • Cirrhosis, Liver
  • +3 more
  • Los Angeles, California
    Michael Y Lin
Jun 10, 2022

Hypertension Trial in Worldwide (Placebo, ALN-AGT01)

Recruiting
  • Hypertension
  • Birmingham, Alabama
  • +112 more
Dec 16, 2022

Hypertension Trial in Worldwide (Olmesartan, Amlodipine, Indapamide)

Recruiting
  • Hypertension
  • Birmingham, Alabama
  • +119 more
Jan 13, 2023

Angiotensin-Dependent Arterial and Renal Vasoconstriction in

Recruiting
  • Hormone Therapy
  • Angiotensin II
  • Calgary, Alberta, Canada
    University of Calgary
Jun 28, 2022

Hypertension, Insulin Resistance Trial in Boston (Para-aminohippuric Acid, Angiotensin II, Norepinephrine)

Active, not recruiting
  • Hypertension
  • Insulin Resistance
  • Para-aminohippuric Acid
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 28, 2022

Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers

Recruiting
  • Cognitively Normal Older Adults
  • +3 more
  • Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
  • PCP
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

The Effect of RAAS Blockers on ACE2 Levels

Completed
  • Renin-Angiotensin System
  • ACE inhibitor ,angiotensin receptor blockers
  • Cairo, Select A State Or Province, Egypt
    Ainshams University
Jun 10, 2022

COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II

Recruiting
  • COVID-19
  • Cardiovascular Diseases
  • Angiotensin converting enzyme inhibitor
  • Angiotensin II Receptor Blockers
  • Maceio, Alagoas, Brazil
  • +30 more
Jan 13, 2023

Hypertension, Renal Denervation, Genetic Predisposition Trial in Homburg, Erlangen, Glasgow (Genetic based analysis of

Active, not recruiting
  • Hypertension
  • +2 more
  • Genetic based analysis of identifying predictors of blood pressure in patients after renal denervation
  • Homburg, Saarland, Germany
  • +2 more
Jan 10, 2022

Myocardial Infarction, Adherence, Patient Trial in Ryazan' (The remote monitoring system)

Active, not recruiting
  • Myocardial Infarction
  • Adherence, Patient
  • The remote monitoring system
  • Ryazan', Russian Federation
    RyazSMU
Nov 6, 2021

Distributive Shock Trial in Chicago (Angiotensin II, Placebo)

Not yet recruiting
  • Distributive Shock
  • Angiotensin II
  • Placebo
  • Chicago, Illinois
    Northwestern University
Feb 13, 2022